Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1982 Mar;21(3):416–420. doi: 10.1128/aac.21.3.416

Penetration of ceforanide and cefamandole into the right atrial appendage, pericardial fluid, sternum, and intercostal muscle of patients undergoing open heart surgery.

L D Mullany, M A French, C H Nightingale, H B Low, L H Ellison, R Quintiliani
PMCID: PMC181907  PMID: 7103445

Abstract

Doses of 30 mg of ceforanide or cefamandole per kg were administered intravenously to 26 patients just before their chests were opened for coronary artery bypass or cardiac valve replacement surgery. Samples of right atrial appendage, pericardial fluid, plasma, aortic wall, intercostal muscle, and sternum were obtained at different times after the antibiotic was injected, and these samples were assayed for cephalosporin concentration. For ceforanide the pre-bypass plasma half-life was 2.5 h, and the atrial appendage half-life was 2.1 h; for cefamandole the pre-bypass plasma half-life was 0.75 h and the atrial appendage half-life was 0.72 h. At 3 h the concentrations of ceforanide and cefamandole in atrial appendages were 28.0 and 5.0 micrograms/g, respectively. Ceforanide achieved higher and more sustained concentrations in other tissues than cefamandole. Considering the minimal inhibitory concentrations of these drugs for staphylococci, cefamandole and ceforanide should provide adequate protection against infection by these organisms for the duration of the surgical procedure.

Full text

PDF
416

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer G. L., Polk R. E., Duma R. J., Lower R. Comparison of cephalothin and cefamandole prophylaxis during insertion of prosthetic heart valves. Antimicrob Agents Chemother. 1978 Jun;13(6):924–929. doi: 10.1128/aac.13.6.924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burke J. F. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery. 1961 Jul;50:161–168. [PubMed] [Google Scholar]
  3. Cooper R. H., Savitch C. B., Joseph W. P., Mills J. Evaluation of ceforanide as treatment for staphylococcal and streptococcal endocarditis. Antimicrob Agents Chemother. 1981 Feb;19(2):256–259. doi: 10.1128/aac.19.2.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cunha B. A., Gossling H. R., Pasternak H. S., Nightingale C. H., Quintiliani R. The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement. J Bone Joint Surg Am. 1977 Oct;59(7):856–859. [PubMed] [Google Scholar]
  5. Green E. R., Subramanian S., Faden H., Quintiliani R., Nightingale C. H. A comparison of the penetration characteristics of cephapirin and cephalothin into right atrial appendage, muscle, fat, and pericardial fluid of pediatric patients undergoing open-heart operation. Ann Thorac Surg. 1981 Feb;31(2):155–160. doi: 10.1016/s0003-4975(10)61535-4. [DOI] [PubMed] [Google Scholar]
  6. Griffith R. S., Black H. R., Brier G. L., Wolny J. D. Cefamandole: in vitro and clinical pharmacokinetics. Antimicrob Agents Chemother. 1976 Nov;10(5):814–823. doi: 10.1128/aac.10.5.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lee F. H., Pfeffer M., Van Harken D. R., Smyth R. D., Hottendorf G. H. Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans. Antimicrob Agents Chemother. 1980 Feb;17(2):188–192. doi: 10.1128/aac.17.2.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lee F. H., Smyth R. D., Van Harken D. R. Comparative tissue distribution of ceforanide, cefazolin, and cefamandole in rats. Antimicrob Agents Chemother. 1981 Apr;19(4):625–627. doi: 10.1128/aac.19.4.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Leitner F., Misiek M., Pursiano T. A., Buck R. E., Chisholm D. R., DeRegis R. G., Tsai Y. H., Price K. E. Laboratory evaluation of BL-S786, a cephalosporin with broad-spectrum antibacterial activity. Antimicrob Agents Chemother. 1976 Sep;10(3):426–435. doi: 10.1128/aac.10.3.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Miller K. W., McCoy H. G., Chan K. K., Fischer R. P., Lindsay W. G., Seifert R. D., Zaske D. E. Effect of cardiopulmonary bypass on cefazolin disposition. Clin Pharmacol Ther. 1980 Apr;27(4):550–556. doi: 10.1038/clpt.1980.78. [DOI] [PubMed] [Google Scholar]
  11. Nightingale C. H., Klimek J. J., Quintiliani R. Effect of protein binding on the penetration of nonmetabolized cephalosporins into atrial appendage and pericardial fluids in open-heart surgical patients. Antimicrob Agents Chemother. 1980 Apr;17(4):595–598. doi: 10.1128/aac.17.4.595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Randolph J. A., Buck R. E., Price K. E., Leitner F. Comparative bactericidal effect of ceforanide (BL-S 786) and five other cephalosporins in an in vitro pharmacokinetic model. J Antibiot (Tokyo) 1979 Jul;32(7):727–733. doi: 10.7164/antibiotics.32.727. [DOI] [PubMed] [Google Scholar]
  13. Reed W. A. Antibiotics and cardiac surgery. J Thorac Cardiovasc Surg. 1965 Dec;50(6):888–892. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES